Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1994-09-12
1998-08-18
Kight, John
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
424 165, 424 185, A61K 5100, A61M 3614
Patent
active
057955611
ABSTRACT:
Novel radioiodinated analogues of naturally-occurring phospholipid ethers are tumor-specific and have a triglycerol backbone structure which, in certain embodiments, is substituted at the 3-position with an alkyl phosphocholine and include a monoiodinated benzoyl side chain substituted at the 2-position in accordance with the general formula: ##STR1## where n=1-15 ##STR2## M=0-15; Z=.sup.123 I, .sup.125 I, and .sup.131 I; Y=NH.sub.2, NR.sub.2, and NR.sub.3, and R=alkyl, aralkyl.
REFERENCES:
patent: 3716631 (1973-02-01), Steggerda et al.
patent: 4473544 (1984-09-01), Maehulla et al.
patent: 4571332 (1986-02-01), Schroit et al.
patent: 4925649 (1990-05-01), Counsell et al.
patent: 4965391 (1990-10-01), Counsell et al.
patent: 5061626 (1991-10-01), Baldo et al.
patent: 5087721 (1992-02-01), Counsell et al.
patent: 5347030 (1994-09-01), Counsell et al.
Andreesen et al., Cancer Research, vol. 38, pp. 3894-3899, Nov., 1978.
March et al., Advanced Organic Chemistry, p. 1100, 1985.
Counsell Raymond E.
Haradahira Terushi
Meyer Karen L.
Schwendner Susan W.
Jones Dameron
Kight John
The Board of Regents of the University of Michigan
LandOfFree
Radioiodinated phospholipid ether analogues does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radioiodinated phospholipid ether analogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radioiodinated phospholipid ether analogues will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1112431